Air purifiers for allergy symptoms relief
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests if using an air purifier at home can help reduce allergy symptoms like a stuffy or runny nose. It is for people with persistent moderate-to-severe allergic rhinitis caused by indoor allergens like dust mites or pet dander.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 60 years old
- You have moderate to severe allergic rhinitis (allergy affecting your nose) that has been stable for at least one month
- You test positive for dust mites or pet dander by a skin test or blood test
- You spend at least 8 hours a day at home (where the air purifier will be placed)
- You have wi-fi at home and are not already using an air purifier
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called washed microbiota transplantation, which transfers gut bacteria from healthy donors to people with allergic rhinitis. The goal is to see if changing the gut bacteria can reduce allergy symptoms like sneezing, itching, and a runny or blocked nose.
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
This study looks at how pollen, climate, and air pollution affect people with seasonal allergies (chronic rhinitis). It aims to see if these factors worsen symptoms and could help improve allergy care.
This study uses a nasal allergen provocation test to help diagnose chronic rhinitis more accurately. If you have allergic rhinitis or are a healthy volunteer, you may help researchers learn how well this test works.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
Hear when a new Rhinitis Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.